diabetes header graphic


An Update On The Thyroid - Gynecology Connection
By Richard Shames, M.D. & Karilee Shames, Ph.D., R.N.
In recent weeks, it has come to my attention that a great many women are still confused about the interactions between their thyroid hormone and their female hormone balance. The good news is that the estrogen panacea is winding down. The bad news is that a great many women don't know how to proceed with female hormone balance.

The more progressive gynecologists are using bio-identical hormones instead of Premarin & Provera. Nevertheless, estriol and micronized progesterone may still not be yielding the results you would like, unless potential thyroid situations are taken into account. This can be difficult if your gynecologist - like many - is still not using the new TSH guidelines (remember that a TSH level over 2.0 is suspicious for low thyroid, and above 3.0 is diagnostic for it).

When we first wrote our book THYROID POWER, we took the position (for simplicity) that an additional thyroid balance would be available by adjusting female hormones, if needed, then adjusting adrenal hormones, if needed. The reverse of this posture is also quite valid. Further adjustments of thyroid (whether you are being treated for a diagnosed thyroid problem or not) can be of great benefit in your reproductive hormone balance. The interaction between these two hormonal systems is extremely significant. Anyone who has taken birth control pills, or estrogen, needs to keep in mind that one additional effect of that maneuver is to increase thyroid-binding proteins in the blood.

This means that almost any thyroid blood test result is quite suspect, because the regular tests will show plenty of thyroid hormone in the bloodstream, but you may still not have sufficient thyroid hormone in the tissues. In other words, estrogens will make thyroid blood tests even more unreliable than they already are.

What this means is that you can be told you don't have a thyroid problem when you really do. In addition, if you are taking thyroid medicine, you could be told that you're taking plenty, when in the reality of your tissue levels (not measured on blood tests) you need more.

This is not a minor subtlety. It is of critical importance to you. A lack of proper thyroid hormone levels has been implicated in everything from bad PMS to irregular cycles, low libido, infertility, miscarriage, endometriosis, polycystic ovary, uterine fibroids, dysfunctional bleeding, severe menopause, and osteoporosis. With a long list of possible gynecological problems such as this, you are well advised to optimize your



thyroid function as much as possible.

So once again I return to a recurrent theme in my office & coaching practice: if there has been any thyroid, diabetes, migraine, colitis, rheumatoid or other autoimmune problems in your family, then you are likely to have some degree of thyroid involvement yourself. This is especially true approaching and during menopause years. The Journal of Epidemiology in 2001 had a compelling art icle revealing that as much as 26% of menopausal women were hypothyroid, making their menopause years worse.

Therefore, you owe it to yourself to do extra diagnostic maneuvers for revealing low thyroid, such as obtaining thyroid antibody testing in addition the routine T3, T4, and TSH. In addition, make sure the T4 determination is the Free T4, and your T3 testing is for both Free T3 and Total T3. Consider asking for a clinical trial of thyroid medicine if you are in the low normal area on these results.

Many of those who have had conventional blood tests, only to be told their symptoms are imaginary, may find a more accurate verdict with a home saliva test. The hormone health group, www.canaryclub.org, offers these home hormone tests at a discount. The information from these tests often confirms the patients own awareness that there is indeed something wrong. This in turn can lead to effective treatment -- and ultimately a return to wellness.

If you are not feeling well, just not up to par, have unwanted pounds, feel depressed for no apparent reason, are having unexpected and seemingly unwarranted male or female issues - don't wait and don't settle for an unsatisfactory diagnosis - get properly tested - then treated. It is easy, inexpensive and can make the world of difference to your life now!

Perhaps even more important is for the person who is already diagnosed and being treated for low thyroid to make sure that your treatment protocol is optimal. In my coaching practice, where I speak with women from all over the country, I frequently find someone who is experiencing uncomfortable symptoms of female hormone imbalance due to an inadequate dose of thyroid medicine. Often these symptoms completely disappear without further female hormone intervention simply through the proper thyroid care alone.

Keep in mind there are at least five (5) different kinds of synthetic thyroid, and five (5) different kinds of natural thyroid, in addition to Armour. Sometimes it's not just the dose of your medicine, it's the type or brand - and don't forget that many women need a mix of thyroids rather than just one type.

*****

Article Directory: http://www.articlecube.com

The Canary Club was started by Lynn Larkin and Judith Seton, two women who had been through the mill with ineffective testing resulting in inadequate care. They are now ready and willing to work with you to create an effective vehicle for healthy change. We would like to invite each of you to participate in a consumer-advocacy group (www.CanaryClub.org) that allows people from all over the country to self-order a home hormone test kit for concurrent evaluation of these three major hormones. Drs Shames can be reached at www.FeelingFFF.com

AddThis Social Bookmark Button




Here are some more diabetes articles...
The Feds & Weight Loss
By J. Brian Keith
Current info about weight loss and the federal government is not always the easiest thing to locate. Fortunately, this report includes the latest weight loss and the federal government info Read more...
Weight Loss And Other Health Benefits Of The Low Glycemic Index Diet
By Laurie
You may not believe it, but stevia's main extract, stevioside is about 300 times as sweet as table sugar. Even its dried leaves are at least 30 times sweeter than sugar. What is extremely Read more...

Study of 24 Hour Blood Pressure and the Association to Complications to Type 1 Diabetes
<b>Conditions</b>:   Type 1 Diabetes;   Hypertension<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   Steno Diabetes Center<br/><b>Recruiting</b> - verified April 2010
A Study on the Prevalence of Obstructive Sleep Apnea in Patients With Type II Diabetes Mellitus
<b>Conditions</b>:   Obstructive Sleep Apnea;   Diabetes Mellitus<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   The University of Hong Kong<br/><b>Completed</b> - verified July 2010
Efficacy and Safety of Ranibizumab in Two "Treat and Extend" Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes Mellitus
<b>Condition</b>:   Diabetic Macular Edema<br/><b>Interventions</b>:   Drug: Ranibizumab;   Drug: ranibizumab;   Drug: ranibizumab<br/><b>Sponsor</b>:   Novartis Pharmaceuticals<br/><b>Not yet recruiting</b> - verified July 2010
To Evaluate if Wide Glucose Fluctuations Lead to Injury of Heart Nerves
<b>Condition</b>:   Type 1 Diabetes Mellitus<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   University of Michigan<br/><b>Recruiting</b> - verified May 2010
Optimized Strategy for Diabetic Patients With Critical Limb Ischemia(Part I)
<b>Conditions</b>:   Vascular Diseases;   Diabetes<br/><b>Interventions</b>:   Device: femoral-popliteal bypass;   Device: stent<br/><b>Sponsors</b>:   Peking Union Medical College Hospital;   Beijing Tongren Hospital;   Xuanwu Hospital, Beijing<br/><b>Not yet recruiting</b> - verified July 2010
Comparing Safety and Efficacy of NN5401 With Insulin Glargine in Subjects With Type 2 Diabetes: An Extension to Trial NN5401-3590
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: NN5401;   Drug: insulin glargine<br/><b>Sponsor</b>:   Novo Nordisk<br/><b>Recruiting</b> - verified July 2010
Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by Metformin
<b>Condition</b>:   Type 2 Diabetes Mellitus<br/><b>Interventions</b>:   Drug: LIXISENATIDE (AVE0010);   Drug: Placebo<br/><b>Sponsor</b>:   Sanofi-Aventis<br/><b>Recruiting</b> - verified July 2010
Does Vitamin D Reduce Risk of Developing Type II DM in High Risk Individuals
<b>Condition</b>:   Type 2 Diabetes Mellitus<br/><b>Interventions</b>:   Drug: Vitamin D3;   Drug: Placebo<br/><b>Sponsor</b>:   King Faisal Specialist Hospital & Research Center<br/><b>Not yet recruiting</b> - verified July 2010
Does Vitamin D Improve Glycemic Control in Type II DM?
<b>Conditions</b>:   Diabetes Mellitus;   Vitamin D Deficiency<br/><b>Interventions</b>:   Drug: vitamin D3 2000 IU;   Drug: vitamin D3 5000 IU;   Drug: Placebo<br/><b>Sponsor</b>:   King Faisal Specialist Hospital & Research Center<br/><b>Not yet recruiting</b> - verified July 2010
Insulin Dosage Software Program for People With Type 1 and Type 2 Diabetes
<b>Conditions</b>:   Diabetes;   Insulin<br/><b>Intervention</b>:   Device: insulin dose software<br/><b>Sponsors</b>:   Park Nicollet Institute;   National Institutes of Health (NIH);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   Hygieia, Inc;   International Diabetes Center at Park Nicollet<br/><b>Recruiting</b> - verified June 2010
Type 2 Diabetes and Obesity in Mexican Pimas: Gene-Environment Interaction
<b>Condition</b>:   Type 2 Diabetes Mellitus<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Recruiting</b> - verified June 2010
Evaluation of the Effectiveness and Safety of Physician Versus Patient-led of Insulin Glargine Initiation and Titration in Type 2 Diabetes Mellitus
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Intervention</b>:   Drug: Insulin Glargine<br/><b>Sponsor</b>:   Sanofi-Aventis<br/><b>Not yet recruiting</b> - verified July 2010
A Study Comparing the Safety, Tolerance, and Efficacy of Various Doses of SK-0403 Versus Placebo and Sitagliptin 100 mg in Patients Not Well-Controlled on Metformin Therapy
<b>Condition</b>:   Type 2 Diabetes<br/><b>Interventions</b>:   Drug: SK-0403;   Drug: Placebo;   Drug: Sitagliptin<br/><b>Sponsor</b>:   Kowa Research Institute, Inc.<br/><b>Not yet recruiting</b> - verified June 2010
Tu Salud Si Cuenta: UT Community Outreach Program for Community-based Diabetes Prevention and Control.
<b>Condition</b>:   Diabetes, Obesity<br/><b>Intervention</b>:   Behavioral: Tu Salud Si Cuenta Behavioral Intervention<br/><b>Sponsor</b>:   The University of Texas Health Science Center, Houston<br/><b>Recruiting</b> - verified July 2010
Hypothalamic Function Before and After Bariatric Surgery
<b>Conditions</b>:   Obesity;   Diabetes<br/><b>Interventions</b>:   Procedure: Roux en Y gastric bypass and lap. gastric banding;   Behavioral: Prodimed dietary intervention<br/><b>Sponsor</b>:   Leiden University Medical Center<br/><b>Recruiting</b> - verified January 2010
Evaluation of Single Nucleotide Polymorphisms (SNPs) in Patients With and Without Diabetic Macular Edema
<b>Conditions</b>:   Diabetic Retinopathy;   Diabetic Macular Edema<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   National Eye Institute (NEI)<br/><b>Recruiting</b> - verified July 2010
Psoriasis Inflammation and Systemic Co Morbidities
<b>Condition</b>:   Psoriasis<br/><b>Intervention</b>:   <br/><b>Sponsors</b>:   Rockefeller University;   Weill Medical College of Cornell University<br/><b>Recruiting</b> - verified July 2010
The Effectiveness of Lubiprostone in Constipated Diabetics
<b>Conditions</b>:   Constipation;   Diabetes;   Colon Transit<br/><b>Intervention</b>:   Drug: Lubiprostone<br/><b>Sponsor</b>:   Emory University<br/><b>Not yet recruiting</b> - verified July 2010
Noninvasive Transcutaneous Glucometer Development
<b>Conditions</b>:   Healthy;   Prediabetic State (IGT);   Diabetes Mellitus, Type 2;   Diabetes Mellitus, Type 1<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   InLight Solutions<br/><b>Completed</b> - verified February 2008
Left Atrial Distensibility to Predict Left Ventricular Filling Pressure and Prognosis in Patients With Severe Mitral Regurgitation
<b>Conditions</b>:   Mitral Valve Insufficiency;   Atrial Fibrillation;   Heart Failure<br/><b>Intervention</b>:   Procedure: Cardiac catheterization<br/><b>Sponsors</b>:   Kaohsiung Veterans General Hospital.;   National Science Council, Taiwan<br/><b>Recruiting</b> - verified June 2010
Comprehensive Analyses of Multidetector-row Cardiac Computed Tomography Data in Koreans
<b>Condition</b>:   Coronary Disease<br/><b>Intervention</b>:   <br/><b>Sponsors</b>:   Seoul National University Bundang Hospital;   The Korean Society of Lipidology and Atherosclerosis<br/><b>Recruiting</b> - verified June 2010
Effect of Recombinant Human Growth Hormone (rhGH) Administration on Visceral Adiposity and Markers of Cardiovascular Risk in Obese Adolescent Girls
<b>Condition</b>:   Obesity<br/><b>Interventions</b>:   Drug: recombinant human growth hormone (rhGH);   Drug: Placebo<br/><b>Sponsors</b>:   Massachusetts General Hospital;   Genentech<br/><b>Recruiting</b> - verified July 2010
Characterization of the Kinetics of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus (T2DM)
<b>Condition</b>:   Type 2 Diabetes Mellitus<br/><b>Intervention</b>:   Drug: Dapagliflozin<br/><b>Sponsor</b>:   Bristol-Myers Squibb<br/><b>Not yet recruiting</b> - verified July 2010
Prevention of Postprandial Hyperglycemia by Acarbose May be a Promising Therapeutic Strategy for Reducing the Increased Risk for Cardiovascular Disease.
<b>Condition</b>:   Diabetes Mellitus<br/><b>Intervention</b>:   Drug: Glucobay (Acarbose, BAYG5421)<br/><b>Sponsor</b>:   Bayer<br/><b>Completed</b> - verified July 2010
Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: insulin aspart;   Drug: insulin detemir;   Drug: insulin aspart;   Drug: insulin detemir<br/><b>Sponsor</b>:   Novo Nordisk<br/><b>Not yet recruiting</b> - verified July 2010
Effect of Pioglitazone on Mitochondrial Function in Muscle and Adipose Tissue in Humans
<b>Condition</b>:   Type II Diabetes Mellitus<br/><b>Intervention</b>:   <br/><b>Sponsors</b>:   Arizona State University;   Takeda Pharmaceuticals North America, Inc.<br/><b>Recruiting</b> - verified July 2010
Vitamin D in Vulnerable Adults
<b>Conditions</b>:   Frail Elderly;   Vitamin D Deficiency<br/><b>Interventions</b>:   Dietary Supplement: vitamin D;   Dietary Supplement: placebo<br/><b>Sponsor</b>:   Department of Veterans Affairs<br/><b>Not yet recruiting</b> - verified July 2010
Left Atrial Distensibility and Left Ventricular Filling Pressure in Acute Myocardial Infarction
<b>Condition</b>:   Myocardial Infarction<br/><b>Intervention</b>:   Procedure: Primary percutaneous coronary intervention<br/><b>Sponsors</b>:   Kaohsiung Veterans General Hospital.;   No other funding source in this study<br/><b>Completed</b> - verified December 2007
Use of Bevacizumab in Trabeculectomy Surgery
<b>Conditions</b>:   Glaucoma;   Optic Neuropathy;   Fibrosis<br/><b>Interventions</b>:   Drug: Bevacizumab;   Drug: Control<br/><b>Sponsors</b>:   Sunnybrook Health Sciences Centre;   Glaucoma Research Society of Canada<br/><b>Recruiting</b> - verified July 2010
Safety and Efficacy Study Comparing 3 New Types of Coronary Stents
<b>Conditions</b>:   Coronary Artery Disease;   Stents;   Coronary Thrombosis<br/><b>Interventions</b>:   Device: coronary stent placement;   Device: Coronary stent placement;   Device: coronary stent placement<br/><b>Sponsor</b>:   University Hospital, Basel, Switzerland<br/><b>Recruiting</b> - verified July 2010
Establishment of Biomarkers for Fabry Disease
<b>Condition</b>:   Fabry Disease<br/><b>Intervention</b>:   Other: Fluorescein angiography<br/><b>Sponsors</b>:   Ohio State University;   Genzyme<br/><b>Not yet recruiting</b> - verified July 2010
The Intervention Nurses Start Infants Growing on Healthy Trajectories (INSIGHT) Study
<b>Conditions</b>:   Infant;   Obesity<br/><b>Interventions</b>:   Behavioral: Child Safety Insights;   Behavioral: Child Feeding Insights<br/><b>Sponsors</b>:   Penn State University;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Not yet recruiting</b> - verified July 2010
Anticholinergic vs. Botox Comparison Study
<b>Conditions</b>:   Urge Urinary Incontinence;   Overactive Bladder Syndrome<br/><b>Interventions</b>:   Drug: Botulinum toxin A (Botox A®);   Drug: Solifenacin 5mg;   Drug: Solifenacin 10mg;   Drug: Trospium chloride<br/><b>Sponsors</b>:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   Office of Research on Women's Health (ORWH);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Recruiting</b> - verified June 2010
Reducing Dietary Energy Density by Incorporating Vegetables in Order to Decrease Energy Intake
<b>Condition</b>:   Obesity<br/><b>Intervention</b>:   Other: Incorporating vegetables into the diet to reduce energy density<br/><b>Sponsors</b>:   Penn State University;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Active, not recruiting</b> - verified July 2010